FactSet Research [FDS] vs CME [CME] Detailed Stock Comparison
FactSet Research
CME
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: FactSet Research wins in 9 metrics, CME wins in 9 metrics, with 0 ties. Both stocks appear equally matched on key metrics.
View Metrics Details
Vital Metrics Comparison
| Metric | FactSet Research | CME | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 17.80 | 25.52 | FactSet Research |
| Price-to-Book Ratio | 4.78 | 3.42 | CME |
| Debt-to-Equity Ratio | 71.28 | 13.60 | CME |
| PEG Ratio | 0.24 | 1.63 | FactSet Research |
| EV/EBITDA | 12.87 | 21.26 | FactSet Research |
| Profit Margin (TTM) | 25.72% | 58.59% | CME |
| Operating Margin (TTM) | 29.71% | 66.87% | CME |
| EBITDA Margin (TTM) | 29.71% | 66.87% | CME |
| Return on Equity | 29.13% | 13.61% | FactSet Research |
| Return on Assets (TTM) | 11.19% | 1.74% | FactSet Research |
| Free Cash Flow (TTM) | $614.66M | $3.60B | CME |
| Dividend Yield | N/A | 4.30% | N/A |
| 1-Year Return | -38.03% | 21.25% | CME |
| Price-to-Sales Ratio (TTM) | 4.51 | 14.77 | FactSet Research |
| Enterprise Value | $11.66B | $96.67B | CME |
| EV/Revenue Ratio | 5.02 | 15.03 | FactSet Research |
| Gross Profit Margin (TTM) | N/A | 86.90% | N/A |
| Revenue per Share (TTM) | $61 | $18 | FactSet Research |
| Earnings per Share (Diluted) | $15.56 | $10.33 | FactSet Research |
| Beta (Stock Volatility) | 0.79 | 0.43 | CME |
FactSet Research vs CME Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| FactSet Research | 0.02% | 0.28% | -21.74% | -37.08% | -32.05% | -40.58% |
| CME | 0.97% | 2.56% | 4.44% | -1.36% | 5.05% | 16.64% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| FactSet Research | -38.03% | -28.26% | -16.63% | 71.18% | 226.39% | 741.25% |
| CME | 21.25% | 56.47% | 60.03% | 199.04% | 402.50% | 323.77% |
News Based Sentiment: FactSet Research vs CME
FactSet Research
News based Sentiment: MIXED
October presented a mixed bag for FactSet, with an earnings miss and analyst downgrades offset by positive developments like AI integration and decreasing short interest. The stock's volatility and valuation concerns create uncertainty, making it a significant but complex month for investors.
CME
News based Sentiment: MIXED
October was a month of strategic moves for CME Group, with a significant push into 24/7 cryptocurrency trading alongside strong performance in its core metals business and a portfolio streamlining through the OSTTRA sale. However, mixed analyst sentiment and insider selling introduce a degree of caution, making it a mixed but overall positive month for investors.
Performance & Financial Health Analysis: FactSet Research vs CME
| Metric | FDS | CME |
|---|---|---|
| Market Information | ||
| Market Cap | $10.64B | $95.00B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 715,240 | 1,908,770 |
| 90 Day Avg. Volume | 727,873 | 1,922,913 |
| Last Close | $283.13 | $271.45 |
| 52 Week Range | $272.50 - $499.87 | $213.94 - $290.79 |
| % from 52W High | -43.36% | -6.65% |
| All-Time High | $499.87 (Nov 11, 2024) | $290.79 (Jun 02, 2025) |
| % from All-Time High | -43.36% | -6.65% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.06% | 0.10% |
| Quarterly Earnings Growth | 0.72% | 0.16% |
| Financial Health | ||
| Profit Margin (TTM) | 0.26% | 0.59% |
| Operating Margin (TTM) | 0.30% | 0.67% |
| Return on Equity (TTM) | 0.29% | 0.14% |
| Debt to Equity (MRQ) | 71.28 | 13.60 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $57.91 | $77.13 |
| Cash per Share (MRQ) | $9.41 | $5.82 |
| Operating Cash Flow (TTM) | $726.26M | $4.20B |
| Levered Free Cash Flow (TTM) | $519.30M | $2.92B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 4.30% |
| Last 12-Month Dividend | N/A | $11.85 |
Valuation & Enterprise Metrics Analysis: FactSet Research vs CME
| Metric | FDS | CME |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 17.80 | 25.52 |
| Forward P/E | 14.82 | 25.42 |
| PEG Ratio | 0.24 | 1.63 |
| Price to Sales (TTM) | 4.51 | 14.77 |
| Price to Book (MRQ) | 4.78 | 3.42 |
| Market Capitalization | ||
| Market Capitalization | $10.64B | $95.00B |
| Enterprise Value | $11.66B | $96.67B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 5.02 | 15.03 |
| Enterprise to EBITDA | 12.87 | 21.26 |
| Risk & Other Metrics | ||
| Beta | 0.79 | 0.43 |
| Book Value per Share (MRQ) | $57.91 | $77.13 |
Financial Statements Comparison: FactSet Research vs CME
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | FDS | CME |
|---|---|---|
| Revenue/Sales | N/A | $1.64B |
| Cost of Goods Sold | N/A | $206.70M |
| Gross Profit | N/A | $1.44B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | $1.11B |
| EBITDA | N/A | $476.30M |
| Pre-Tax Income | N/A | $1.24B |
| Income Tax | N/A | $288.60M |
| Net Income (Profit) | N/A | $956.20M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | FDS | CME |
|---|---|---|
| Cash & Equivalents | $278.55M | $1.41B |
| Total Current Assets | $707.64M | $123.45B |
| Total Current Liabilities | $481.83M | $121.42B |
| Long-Term Debt | $1.63B | $3.42B |
| Total Shareholders Equity | $2.06B | $27.03B |
| Retained Earnings | $2.10B | $4.69B |
| Property, Plant & Equipment | $197.87M | $371.20M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | FDS | CME |
|---|---|---|
| Operating Cash Flow | $212.28M | $838.30M |
| Capital Expenditures | $-25.23M | $-14.20M |
| Free Cash Flow | $228.60M | $1.10B |
| Debt Repayment | $-542.50M | $-750.00M |
| Common Stock Repurchase | $-80.70M | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | FDS | CME |
|---|---|---|
| Shares Short | 1.75M | 4.63M |
| Short Ratio | 3.83 | 2.42 |
| Short % of Float | 0.05% | 0.01% |
| Average Daily Volume (10 Day) | 715,240 | 1,908,770 |
| Average Daily Volume (90 Day) | 727,873 | 1,922,913 |
| Shares Outstanding | 37.81M | 359.61M |
| Float Shares | 37.63M | 358.80M |
| % Held by Insiders | 0.00% | 0.00% |
| % Held by Institutions | 0.96% | 0.92% |
Dividend Analysis & Yield Comparison: FactSet Research vs CME
| Metric | FDS | CME |
|---|---|---|
| Last 12-Month Dividend | N/A | $11.85 |
| Last 12-Month Dividend Yield | N/A | 4.30% |
| 3-Year Avg Annual Dividend | N/A | $10.10 |
| 3-Year Avg Dividend Yield | N/A | 0.91% |
| 3-Year Total Dividends | N/A | $30.30 |
| Ex-Dividend Date | N/A | Sep 09, 2025 |